Total Payments
$25,901
2024 Payments
$5,066
Companies
53
Transactions
777
Medicare Patients
7,132
Medicare Billing
$2.0M
Payment Breakdown by Category
Food & Beverage$16,943 (65.4%)
Consulting$5,088 (19.6%)
Other$2,800 (10.8%)
Travel$804.19 (3.1%)
Education$266.91 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,943 | 764 | 65.4% |
| Consulting Fee | $5,088 | 4 | 19.6% |
| Honoraria | $2,800 | 3 | 10.8% |
| Travel and Lodging | $804.19 | 2 | 3.1% |
| Education | $266.91 | 4 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,939 | 5 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $4,107 | 126 | $0 (2024) |
| GlaxoSmithKline, LLC. | $3,208 | 136 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,317 | 112 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,543 | 54 | $0 (2024) |
| Becton, Dickinson and Company | $1,375 | 1 | $0 (2024) |
| Mylan Specialty L.P. | $1,023 | 56 | $0 (2024) |
| Covidien LP | $991.02 | 4 | $0 (2017) |
| GENZYME CORPORATION | $634.91 | 21 | $0 (2024) |
| United Therapeutics Corporation | $553.49 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,066 | 143 | Becton, Dickinson and Company ($1,375) |
| 2023 | $3,581 | 149 | GlaxoSmithKline, LLC. ($699.35) |
| 2022 | $4,814 | 156 | Edwards Lifesciences Corporation ($1,350) |
| 2021 | $4,394 | 109 | AstraZeneca Pharmaceuticals LP ($1,494) |
| 2020 | $2,735 | 61 | Edwards Lifesciences Corporation ($1,600) |
| 2019 | $2,540 | 73 | Edwards Lifesciences Corporation ($750.00) |
| 2018 | $1,083 | 52 | Boehringer Ingelheim Pharmaceuticals, Inc. ($278.19) |
| 2017 | $1,689 | 34 | Covidien LP ($991.02) |
All Payment Transactions
777 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Respiratory | ||||||
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Respiratory | ||||||
| 12/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Vifor Pharma, Inc. | Zemaira (Drug) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 12/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: Immunology | ||||||
| 12/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.81 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/10/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Pulmonology | ||||||
| 12/04/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $29.31 | General |
| Category: VTE | ||||||
| 11/26/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $30.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $31.03 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $86.66 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $3.90 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.06 | General |
| 11/01/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $28.86 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.55 | General |
| Category: Immunology | ||||||
| 10/28/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,205 | 5,401 | $1.8M | $567,432 |
| 2022 | 21 | 1,947 | 4,982 | $1.5M | $539,717 |
| 2021 | 19 | 1,606 | 4,087 | $1.0M | $463,950 |
| 2020 | 17 | 1,374 | 4,026 | $961,360 | $469,934 |
Total Patients
7,132
Total Services
18,496
Medicare Billing
$2.0M
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 258 | 1,058 | $613,640 | $186,695 | 30.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 362 | 1,754 | $480,596 | $174,856 | 36.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 317 | 968 | $344,608 | $100,701 | 29.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 149 | 177 | $93,810 | $25,691 | 27.4% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 189 | 270 | $78,570 | $23,957 | 30.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 118 | 118 | $71,862 | $21,842 | 30.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 75 | 94 | $47,000 | $14,001 | 29.8% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 91 | 92 | $6,992 | $4,807 | 68.8% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 89 | 90 | $6,840 | $4,470 | 65.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 91 | 92 | $16,100 | $3,219 | 20.0% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 96 | 99 | $16,335 | $2,904 | 17.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 43 | 168 | $6,888 | $2,058 | 29.9% |
| 94200 | Test to measure largest amount of air breathed in an out | Office | 2023 | 89 | 90 | $5,310 | $1,209 | 22.8% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 93 | 95 | $3,345 | $796.10 | 23.8% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 14 | 14 | $714.00 | $223.02 | 31.2% |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 2023 | 94 | 95 | $2,375 | $2.21 | 0.1% |
| J0517 | Injection, benralizumab, 1 mg | Office | 2023 | 37 | 127 | $1.27 | $1.25 | 98.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 260 | 1,235 | $612,110 | $226,245 | 37.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 344 | 1,554 | $367,481 | $134,279 | 36.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 240 | 698 | $238,371 | $72,109 | 30.3% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 183 | 349 | $87,049 | $32,110 | 36.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 133 | 149 | $70,195 | $24,911 | 35.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 82 | 82 | $49,097 | $15,741 | 32.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 82 | 95 | $45,230 | $14,467 | 32.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 62 | 64 | $4,864 | $3,492 | 71.8% |
About Dr. Samarjit Singh, MD
Dr. Samarjit Singh, MD is a Internal Medicine healthcare provider based in Fountain Valley, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689786139.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samarjit Singh, MD has received a total of $25,901 in payments from pharmaceutical and medical device companies, with $5,066 received in 2024. These payments were reported across 777 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($16,943).
As a Medicare-enrolled provider, Singh has provided services to 7,132 Medicare beneficiaries, totaling 18,496 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Fountain Valley, CA
- Active Since 08/31/2006
- Last Updated 06/11/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689786139
Products in Payments
- HemoSphere (Device) $2,725
- DUPIXENT (Biological) $2,202
- BREZTRI (Drug) $1,901
- NUCALA (Biological) $1,653
- The Swan-Ganz Catheter (Device) $1,600
- TRELEGY ELLIPTA (Drug) $1,156
- OFEV (Drug) $1,053
- superDimension (Device) $991.02
- TEZSPIRE (Biological) $831.44
- STIOLTO RESPIMAT (Drug) $819.55
- FASENRA (Biological) $582.30
- Yupelri (Drug) $491.24
- YUPELRI (Drug) $475.41
- Prolastin-C Liquid (Biological) $467.48
- TYVASO (Drug) $465.62
- Life2000 Ventilation System (Device) $450.00
- FASENRA (Drug) $404.19
- SPIRIVA RESPIMAT (Drug) $300.14
- Impella (Device) $292.94
- ELIQUIS (Drug) $292.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fountain Valley
Truong-Sinh Leduc, M.d, M.D
Internal Medicine — Payments: $274,359
Internal Medicine $274,359
Rufina Pamela Mae Miel, Md, MD
Internal Medicine — Payments: $83,665
Internal Medicine $83,665
Dr. Janet Pan, M.d, M.D
Internal Medicine — Payments: $46,647
Internal Medicine $46,647
Pete Pow-Anpongkul
Internal Medicine — Payments: $26,930
Internal Medicine $26,930
Dr. Hoang Nguyen, M.d, M.D
Internal Medicine — Payments: $19,529
Internal Medicine $19,529
Vinod Malhotra, Md, MD
Internal Medicine — Payments: $16,856
Internal Medicine $16,856